A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Last Updated   March 28, 2025

Want to learn how to participate in this trial?

PLATFORMPACAN1001

OVERVIEW

  • Sexes Eligible for Study
    all
  • Age
    18+ years
  • Phase
    phase 1
    1
  • Sites
    11 Sites
  • Status
     Enrolling by invitation

SUMMARY

The purpose of this study is to collect long-term safety data in participants with cancers including acute myeloid leukemia, non-Hodgkin lymphoma, myelodysplastic syndrome, chronic lymphocytic leukemia (type of cancer of the blood and bone marrow in which the bone marrow makes a large number of abnormal blood cells) and advanced solid tumors and metastatic castration-resistant prostate cancer (mCRPC).

CONDITIONS

  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Non-Hodgkin
  • Myelodysplastic Syndromes
  • Cancer
  • Solid Tumor, Adult
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)

ELIGIBILITY


Inclusion Criteria:

* Have participated in a parent study, with a linked intervention specific appendix (ISA) within this platform study, in which they initially received study treatment(s) prior to rolling over to this platform study
* Satisfy all ISA specific inclusion criteria

More...

DETAILS

LOCATIONS

Locations in:
Belgium, France, Japan, Moldova, Poland, Ukraine, Georgia
Country (7) City or Province (11) Status
Belgium Gent Ghent University Hospital
France Lille Hopital Claude Huriez
France Villejuif Institut Gustave Roussy
Japan Nagoya-shi National Hospital Organization Nagoya Medical Center
Moldova Chisinau Arensia Exploratory Medicine
Poland Gdansk Uniwersyteckie Centrum Kliniczne Osrodek Badan Klinicznych Wczesnych Faz
Poland Krakow Pratia MCM Krakow
Poland Skorzewo Aidport Sp z o o
Ukraine Kyiv Medical Center of Limited Liability Company Arensia Exploratory Medicine
Georgia Tbilisi Arensia Exploratory Medicine
Japan Tokyo The Cancer Institute Hospital of JFCR
Show More
Geo Locations

51.05, 3.71667

50.63297, 3.05858

48.7939, 2.35992

35.18147, 136.90641

47.00556, 28.8575

54.35205, 18.64637

50.06143, 19.93658

52.3906266, 16.7919124

50.45466, 30.5238

41.69411, 44.83368

35.6895, 139.69171

x
50

Indicates 50+ sites in this region: click to zoom in.

10

Indicates 10+ sites in this region: click to zoom in.

5

Indicates < 10 sites in this region: click to zoom in.

Corresponds to individual site.

Interested in participating?